BANGKOK – The first clinical trial on a massive scale of two antimalarial drugs controversially repurposed for use with Covid-19 patients launches this week to determine their efficacy as a prevention rather than treatment against coronavirus illness. The aim is to enroll up to 40,000 front-line health workers in Europe, Africa and Asia in the […]
